A pilot case control follow-up study on hearing in children treated with tobramycin in the newborn period
- 11 September 2002
- journal article
- Published by Elsevier BV in International Journal of Pediatric Otorhinolaryngology
- Vol. 65 (3), 225-232
- https://doi.org/10.1016/s0165-5876(02)00178-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Identification of Neonatal Hearing Impairment: Infants with Hearing LossEar & Hearing, 2000
- Once-daily Gentamicin Dosing in Newborn InfantsPEDIATRICS, 1999
- Familial Progressive Sensorineural Deafness Is Mainly Due to the mtDNA A1555G Mutation and Is Enhanced by Treatment with AminoglycosidesAmerican Journal of Human Genetics, 1998
- Risk Factors of Sensorineural Hearing Loss in Preterm InfantsNeonatology, 1997
- Recording of brainstem evoked potentials and their association with gentamicin in neonatesPediatric Neurology, 1996
- A Critical Reevaluation of the "Therapeutic Range" of AminoglycosidesClinical Infectious Diseases, 1992
- Neonatal status and hearing loss in high-risk infantsThe Journal of Pediatrics, 1989
- Prospective controlled evaluation of auditory function in neonates given netilmicin or amikacinThe Journal of Pediatrics, 1985
- Freedom from ototoxicity in aminoglycoside treated neonates: A mistaken notionThe Laryngoscope, 1981
- Clinical Experience With Impedance AudiometryJAMA Otolaryngology–Head & Neck Surgery, 1970